Welcome & Introduction
Ideal Investigation Pathway for Renal Cell Carcinoma
Best Abstracts in Clinical value ASCO GU 2022 Update
Welcome & Introduction
Newer Neo & Adjuvant treatment options in NSCLC
Recent Advances in Targeted therapy for metastatic Lung Cancer
Welcome & Introduction
Lorlatinib as front Line option in ALK+ mNSCLC
Meeting the unmet need in NSCLC patients with MET exon 14 alterations
Welcome & Introduction
Role of Adjuvant Radiotherapy in Curable Gastric Maglignancies
Debate FLOT Protocol for AII Localy Advanced GE Junction Tumours
Welcome & Introduction
SURGICAL OUTCOMES FROM THE PHASE 3 CHECKMATE 816 TRIAL
Neoadjuvant Pembrolizumab for Early Stage Non Small Cell Lung Cancer